- Home
- PHGE vs LUCY Comparison
PHGE vs LUCY Comparison
Compare PHGE & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- LUCY
- Stock Information
- Founded
- PHGE 2015
- LUCY 2017
- Country
- PHGE Israel
- LUCY United States
- Employees
- PHGE N/A
- LUCY N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- LUCY Ophthalmic Goods
- Sector
- PHGE Health Care
- LUCY Health Care
- Exchange
- PHGE Nasdaq
- LUCY Nasdaq
- Market Cap
- PHGE 11.0M
- LUCY 8.9M
- IPO Year
- PHGE N/A
- LUCY 2022
- Fundamental
- Price
- PHGE $0.39
- LUCY $2.10
- Analyst Decision
- PHGE Strong Buy
- LUCY
- Analyst Count
- PHGE 1
- LUCY 0
- Target Price
- PHGE $15.00
- LUCY N/A
- AVG Volume (30 Days)
- PHGE 3.0M
- LUCY 6.0M
- Earning Date
- PHGE 08-13-2025
- LUCY 08-11-2025
- Dividend Yield
- PHGE N/A
- LUCY N/A
- EPS Growth
- PHGE N/A
- LUCY N/A
- EPS
- PHGE N/A
- LUCY N/A
- Revenue
- PHGE N/A
- LUCY $1,707,470.00
- Revenue This Year
- PHGE N/A
- LUCY $367.48
- Revenue Next Year
- PHGE N/A
- LUCY $166.67
- P/E Ratio
- PHGE N/A
- LUCY N/A
- Revenue Growth
- PHGE N/A
- LUCY 22.75
- 52 Week Low
- PHGE $0.34
- LUCY $1.57
- 52 Week High
- PHGE $3.48
- LUCY $11.16
- Technical
- Relative Strength Index (RSI)
- PHGE 37.11
- LUCY 43.54
- Support Level
- PHGE $0.38
- LUCY $2.10
- Resistance Level
- PHGE $0.77
- LUCY $2.20
- Average True Range (ATR)
- PHGE 0.06
- LUCY 0.13
- MACD
- PHGE -0.00
- LUCY 0.01
- Stochastic Oscillator
- PHGE 6.52
- LUCY 25.64
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.